Stacie Seidel

Senior Scientist, Viral Vectors

About Stacie

Stacie has over 12 years of industry experience in molecular & vector biology and protein engineering. She is responsible for building up lentiviral vector (LVV) & adeno-associated virus (AAV) production platforms and next generation plasmid systems.

Prior to ElevateBio, Stacie worked in the Upstream Process Development group at Homology Medicines, where she led a team developing next generation plasmid design for AAV therapeutics and served on several CMC teams. Before Homology Medicines, Stacie was a part of the Vector Biology group at Bluebird Bio, designing and engineering novel CAR T and TCR therapeutics including bb2121. Stacie also worked on a novel rFVIIIFc protein (ELOCATE®) for Hemophilia A while at Biogen.

Education & Accomplishments
Stacie has a BS in Biochemistry and Molecular Biology from the University of Maine and a Master’s in Biotechnology from Harvard University.

Check out our open roles

Interested in working with people like Stacie? We’re looking for pioneers and innovative thinkers committed to developing the next-generation of cell and gene therapies. Review our open roles and find your future.

apply now
“I was drawn to ElevateBio’s collaborative culture and am inspired by our mission to bring new therapies to patients.”
Life @ElevateBio
Meet the talented people who make ElevateBio a great place to work.
meet the team